首页> 外文期刊>Lab on a chip >Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties
【24h】

Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties

机译:具有增强的细胞摄取和免疫刺激特性的壳聚糖/ CpG寡脱氧核苷酸纳米颗粒的微流体生成

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chitosan/cytosine-phosphodiester-guanine oligodeoxynucleotide (CpG ODN) nanoparticles as potential immunostimulatory adjuvants were synthesized by the conventional bulk mixing (BM) method and a novel microfluidic (MF) method. Their size and size distribution, CpG ODN loading efficiency, surface charge, biocompatibility, cellular uptake, and immunostimulatory response were investigated. In the BM method, nanoparticles were synthesized by vortexing a mixture of chitosan solution and CpG ODN2006x3-PD solution. In the MF method, the nanoparticles were synthesized by rapidly mixing a chitosan solution and CpG ODN solution in a poly(dimethylsiloxane) microfluidic device. Our results indicated that particle size and size distribution, CpG ODN loading efficiency, and surface charge could be easily adjusted by using the tuning preparation method and controlling the flow ratio of fluid rates in the different microfluidic channels. Compared with the BM method, the MF method yielded a decrease in particle size and size range, an increase in CpG ODN loading efficiency, and a decrease in surface charge. After the particles were exposed to 293XL-hTLR9 cells, a water-soluble tetrazolium salt assay indicated that the BM and MF-processed nanoparticles had no significant toxicity and were biocompatible. An immunochemical assay indicated that both types of nanoparticles entered 293XL-hTLR9 cells and were located in the endolysosomes. The MF-processed nanoparticles showed much higher cellular uptake efficiency. After the particles were exposed to peripheral blood mononuclear cells, an enzyme-linked immunosorbent assay quantitatively indicated that both types of nanoparticles stimulated the production of interleukin-6 and the MF-processed nanoparticles showed a much stronger immunostimulatory response. These results indicate that the MF method can be used to synthesize nanoparticles with a controllable size and size range for enhancing the biological activity of DNA and other biomolecules.
机译:壳聚糖/胞嘧啶-磷酸二酯-鸟嘌呤寡聚脱氧核苷酸(CpG ODN)纳米粒子作为潜在的免疫刺激佐剂通过常规的批量混合(BM)方法和新型微流控(MF)方法合成。研究了它们的大小和大小分布,CpG ODN装载效率,表面电荷,生物相容性,细胞摄取和免疫刺激反应。在BM方法中,通过涡旋壳聚糖溶液和CpG ODN2006x3-PD溶液的混合物来合成纳米颗粒。在MF方法中,通过在聚(二甲基硅氧烷)微流体装置中快速混合壳聚糖溶液和CpG ODN溶液来合成纳米颗粒。我们的结果表明,通过使用调节制备方法并控制不同微流体通道中流体速率的流量比,可以轻松地调节粒径和粒径分布,CpG ODN的负载效率和表面电荷。与BM方法相比,MF方法可降低粒径和尺寸范围,提高CpG ODN的装载效率,并降低表面电荷。将颗粒暴露于293XL-hTLR9细胞后,水溶性四唑盐分析表明,经BM和MF处理的纳米颗粒无明显毒性,且具有生物相容性。免疫化学分析表明,两种类型的纳米颗粒均进入293XL-hTLR9细胞,并位于溶酶体中。经MF处理的纳米颗粒显示出更高的细胞吸收效率。颗粒暴露于外周血单核细胞后,酶联免疫吸附试验定量表明,两种类型的纳米颗粒均能刺激白介素6的产生,而经MF处理的纳米颗粒表现出更强的免疫刺激反应。这些结果表明,MF法可用于合成具有可控制的大小和大小范围的纳米颗粒,以增强DNA和其他生物分子的生物活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号